Ambroxol for the treatment of COVID-19 among hospitalized patients: A multicenter retrospective cohort study

Ambroxol for the treatment of COVID-19 among hospitalized patients: A multicenter retrospective cohort study

Ambroxol is a commonly used mucolytic agent principally used to treat respiratory diseases, which may have a role as adjunctive therapy for severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2) infection, but there is lack of evidence about its effectiveness on coronavirus disease-2019 (COVID...

Full description

Bibliographic Details
Main Authors:	Yun Lu, Qing-qing Yang, Lin Zhuo, Kun Yang, Hao Kou, Su-yu Gao, Wen Hu, Qiao-li Jiang, Wen-jing Li, Dong-fang Wu, Feng Sun, Hong Cheng, Siyan Zhan
Format:	Article
Language:	English
Published:	Frontiers Media S.A. 2022-10-01
Series:	Frontiers in Microbiology
Subjects:	ambroxol COVID-19 clinical outcomes effectiveness SARS-CoV-2
Online Access:	https://www.frontiersin.org/articles/10.3389/fmicb.2022.1013038/full

Similar Items

Ambroxol therapy for Parkinson’s disease: Systematic literature review
by: Virgi Mayang Maharani, et al.
Published: (2023-06-01)

Ambroxol hydrochloride spray (Luo Runchang®) in the treatment of acute respiratory infectious diseases: a prospective, multicenter, open label, randomized controlled study
by: Lu Cheng, et al.
Published: (2024-09-01)

PERBANDINGAN MUTU FISIK TABLET AMBROXOL MEREK DAGANG X DANTABLETMBROXOL GENERIK
by: oktavia friski, et al.
Published: (2018-02-01)

The use of Ambroxol for the treatment of Gaucher disease: A systematic review
by: Diego Agustín Abelleyra Lastoria, et al.
Published: (2024-02-01)

Cost-effectiveness of ambroxol in the treatment of Gaucher disease type 2
by: Milosavljević Miloš N., et al.
Published: (2024-05-01)

Thermo-Analytical and Compatibility Study with Mechanistic Explanation of Degradation Kinetics of Ambroxol Hydrochloride Tablets under Non-Isothermal Conditions
by: Dijana Jelić, et al.
Published: (2021-11-01)

Efficacy of high-dose ambroxol for paraquat poisoning: A meta-analysis of randomized controlled trials
by: Junwu Wang, et al.
Published: (2020-01-01)

Efficacy of Ambroxol Combined with Loquat Syrup on Bacterial Pneumonia in Mice
by: Li C, et al.
Published: (2024-11-01)

Meta-analysis of the efficacy of budesonide and ambroxol hydrochloride inhalation in children with pneumonia and their effects on inflammatory response
by: Huanan Shen, et al.
Published: (2023-11-01)

ANALYSIS OF QUALITY INDICATORS AND PARAMETRS OF SYRUP AMBROXOL PRODUCTION USING STATISTICAL METHODS
by: S. N. Egorova, et al.
Published: (2019-01-01)

Evaluation of the efficacy and safety of a combination drug containing ambroxol, guaifenesin, and levosalbutamol versus a fixed-dose combination of bromhexine/guaifenesin/salbutamol in the treatment of productive cough in adult patients with acute bronchitis
by: Andrey A. Zaitsev, et al.
Published: (2023-04-01)

Rapid and long‐lasting efficacy of high‐dose ambroxol therapy for neuronopathic Gaucher disease: A case report and literature review
by: Kanako Higashi, et al.
Published: (2024-04-01)

Evaluating the mucolytic effectiveness of Ambroxol and N-Acetylcysteine in patients with Acute exacerbation of chronic obstructive pulmonary disease
by: Aswin A. Anil, et al.
Published: (2024-11-01)

Does Ambroxol alleviate kidney ischemia-reperfusion injury in rats?
by: Çağrı Gültekin, et al.
Published: (2022-08-01)

Ambroxol Hydrochloride Improves Motor Functions and Extends Survival in a Mouse Model of Familial Amyotrophic Lateral Sclerosis
by: Alexandra Bouscary, et al.
Published: (2019-08-01)

Co-aerosolized Pulmonary Surfactant and Ambroxol for COVID-19 ARDS Intervention: What Are We Waiting for?
by: Pradeep Kumar
Published: (2020-09-01)

Exploring the efficacy and safety of Ambroxol in Gaucher disease: an overview of clinical studies
by: Feda E. Mohamed, et al.
Published: (2024-02-01)

Beneficial effects of ambroxol hydrochloride on pentylenetetrazol-induced convulsion model in rats
by: Eda Sunnetci, et al.
Published: (2020-12-01)

Cross linked plantain starch-urea as a polymer in matrix tablets of ambroxol hydrochloride
by: Adenike Okunlola, et al.
Published: (2021-04-01)

Study protocol of the GRoningen early-PD Ambroxol treatment (GREAT) trial: a randomized, double-blind, placebo-controlled, single center trial with ambroxol in Parkinson patients with a GBA mutation
by: O. Siemeling, et al.
Published: (2024-05-01)

Ambroxol as a novel disease-modifying treatment for Parkinson’s disease dementia: protocol for a single-centre, randomized, double-blind, placebo-controlled trial
by: C. R. A. Silveira, et al.
Published: (2019-02-01)

Ambroxol Hydrochloride Loaded Gastro-Retentive Nanosuspension Gels Potentiate Anticancer Activity in Lung Cancer (A549) Cells
by: Shadab Md, et al.
Published: (2021-11-01)

Rational mucolytic therapy with ambroxol: controversial and indisputable. A review
by: Sergey L. Babak, et al.
Published: (2023-09-01)

Development and Characterization of Spray-Dried Combined Levofloxacin–Ambroxol Dry Powder Inhaler Formulation
by: Ruwani K. Suraweera, et al.
Published: (2024-11-01)

Development and Validation of Salbutamol, Bromhexine, Ambroxol and Guauaifenesin Determination in Human Plasma by HPLC-MS/MS Method
by: T. N. Komarov, et al.
Published: (2019-11-01)

The ANeED study – ambroxol in new and early dementia with Lewy bodies (DLB): protocol for a phase IIa multicentre, randomised, double-blinded and placebo-controlled trial
by: Luiza Jadwiga Chwiszczuk, et al.
Published: (2023-05-01)

РАЦИОНАЛЬНОЕ ЛЕЧЕНИЕ КАШЛЯ НА ЭТАПЕ ПЕРВИЧНОГО МЕДИКО-САНИТАРНОГО ЗВЕНА И В УСЛОВИЯХ СТАЦИОНАРА. ДИСКУССИЯ
by: В. И. Трофимов, et al.
Published: (2013-08-01)

Evaluation of safety and efficacy of inhaled ambroxol in hospitalized adult patients with mucopurulent sputum and expectoration difficulty
by: Zeguang Zheng, et al.
Published: (2023-05-01)

Beyond Use Date (BUD) Determination of Ambroxol Hydrochloride Syrup by High-Performance Liquid Chromatography – UV/VIS Detector
by: Catur Jatmika, et al.
Published: (2023-04-01)

Ambroxol hydrochloride alleviates acute lung injury induced by gastric juice aspiration in rats
by: CUI Yi-yao, WANG Feng, LYU Xiao-shuo, LIU Chun-quan, XU Kai-kai, CUI Yong
Published: (2022-08-01)

Ambroxol Treatment Suppresses the Proliferation of <i>Chlamydia pneumoniae</i> in Murine Lungs
by: Dávid Kókai, et al.
Published: (2021-04-01)

Impact of COVID-19 convalescence on pregnancy outcomes in patients undergoing IVF/ICSI during fresh ART cycles: a retrospective cohort study
by: Mingya Cao, et al.
Published: (2024-01-01)

Comparative Study for Spectrofluorimetric Determination of Ambroxol Hydrochloride Using Aluminum Metal Transfer Chelation Complex and Biogenic Synthesis of Aluminum Oxide Nanoparticles Using <i>Lavandula spica</i> Flowers Extract
by: Najla S. Al-Humud, et al.
Published: (2023-02-01)

Optimal surgical timing for lung cancer following SARS-CoV-2 infection: a prospective multicenter cohort study
by: Ziyun Shen, et al.
Published: (2024-10-01)

Comparison of Different Antiviral Regimens in the Treatment of Patients with Severe COVID-19: A Retrospective Cohort
by: Mohammad E. M. Mahfouz, et al.
Published: (2023-01-01)

Prolonged lymphopenia and prognoses among inpatients with different respiratory virus infections: A retrospective cohort study
by: Guohui fan, et al.
Published: (2024-06-01)

Clinical characteristics and risk factors for in-hospital mortality of COVID-19 patients in Hubei Province: A multicenter retrospective study
by: Wu He, et al.
Published: (2025-02-01)

Increased risk for signs and clinical symptoms associated with sedentary behaviour in people diagnosed with COVID-19: a retrospective observational study
by: Lisa Mazzonetto, et al.
Published: (2024-09-01)

Risk of death, hospitalization and intensive care unit admission by SARS-CoV-2 variants in Peru: a retrospective study
by: Diego Fano-Sizgorich, et al.
Published: (2023-02-01)

Clinical characteristics of 9 cancer patients with SARS-CoV-2 infection
by: Yong Zeng, et al.
Published: (2020-05-01)